1. Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia 2. Research Institute of Neurosciences and Medicine, Novosibirsk, Russia 3. N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Novosibirsk, Russia
Using the model of cyclophosphamide (CP)-induced immunosuppression in C57BL/6 mice, the hepatotropic effects of a conjugate of betulonic acid with 9-(4-methylpiperazin-1-ylmethyl)-2-(1,2,3-triazolyl) oreozelone (BABC) have been studied. In the liver of treated animals the expression of genes for cytochromes (CYP 1A1, CYP 1A2, CYP 3A44, CYP 2B10, CYP 2C29, CYP 17A1), PPARA, and cytokines (TNF-α, IL-1β, IL-12α, IL-10) and the relative levels of NF-κB p65, GST-π, and NAT-1 proteins were determined. On day six after administration of the compound and CP to animals a significant (3.2-fold) increase in the expression of the CYP 2B10 as compared to the control group was observed. Treatment of mice with the compound and CP also caused a 2.4-fold increase in the mRNA level of the pro-inflammatory TNF-α gene as compared to the group of animals receiving CP. Administration of the studied compound to intact animals was accompanied by a 2.5-fold increase in the IL-1β expression and a 1.8-fold decrease in the IL-10 expression as compared to the control group. An increase in the expression of pro-inflammatory cytokine genes in the liver of animals treated with the compound was accompanied by an increase in the content of NF-κB p65 (by 1.6 times), as well as an increase in the relative amount of NAT-1 protein (by 2.7 times) as compared to control animals.
Mosalev K.I., Ivanov I.D., Tenditnik M.V., Shults E.E., Vavilin V.A. (2024) Hepatotropic activity of a betulonic acid based compound. Biomeditsinskaya Khimiya, 70(1), 15-24.
Mosalev K.I. et al. Hepatotropic activity of a betulonic acid based compound // Biomeditsinskaya Khimiya. - 2024. - V. 70. -N 1. - P. 15-24.
Mosalev K.I. et al., "Hepatotropic activity of a betulonic acid based compound." Biomeditsinskaya Khimiya 70.1 (2024): 15-24.
Mosalev, K. I., Ivanov, I. D., Tenditnik, M. V., Shults, E. E., Vavilin, V. A. (2024). Hepatotropic activity of a betulonic acid based compound. Biomeditsinskaya Khimiya, 70(1), 15-24.
References
Sorokina I.V, Baev D.S., Zhukova N.A., Tolstikova T.G., Antimonova A.N., Petrenko N.I., Shul'ts E.E., Grigor'ev I.A. (2013) Hepatoprotective activity of betulonic acid amides containing piperidine or pyrrolidinenitroxide moieties. Russian Journal of Bioorganic Chemistry, 39(6), 668-670. CrossRef Scholar google search
Lipeeva A.V., Dolgikh M.P., Shults E.E., Tolstikova T.G. (2020) Astudy of plant coumarins. 18. Conjugates of coumarins with lupane triterpenoids and 1,2,3-triazoles: Synthesis and anti-inflammatory activity. Russian Journal of Bioorganic Chemistry, 46(2), 125-132. CrossRef Scholar google search
Mosalev K.I., Ivanov I.D., Miroshnichenko S.M., Tenditnik M.V., Bgatova N.P., Shults E.E., Vavilin V.A. (2023) The immunomodulatory activity of the betulonic acid based compound. Biomeditsinskaya Khimiya, 69(4), 219-227. CrossRef Scholar google search
Ramirez D.A., Collins K.P., Aradi A.E., Conger K.A., Gustafson D.L. (2019) Kinetics of cyclophosphamide metabolism in humans, dogs, cats, and mice and relationship to cytotoxic activity and pharmacokinetics. Drug Metab. Dispos., 47(3), 257-268. CrossRef Scholar google search
Jumabaeva B.T., Biryukova L.S. (2015) Vidal specialist: Oncology: Handbook — 12th edition, Vidal Rus, Moscow, 384 p. Scholar google search
Rendic S., Guengerich F.P. (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem. Res. Toxicol, 28, 38-42. CrossRef Scholar google search
Ye W., Chen R., Chen X., Huang B., Lin R., Xie X., Chen J., Jiang J., Deng Y., Wen J. (2019) AhR regulates the expression of human cytochrome P450 1A1 (CYP1A1) by recruiting Sp1. FEBS J., 286, 4215-4231. CrossRef Scholar google search
Androutsopoulos V.P., Tsatsakis A.M., Spandidos D.A. (2009) Cytochrome P450 CYP1A1: Wider roles in cancer progression and prevention. BMC Cancer, 9, 187. CrossRef Scholar google search
Chen Y., Zeng L., Wang Y., Tolleson W.H., Knox B., Chen S., Ren Z., Guo L., Mei N., Qian F., Huang K., Liu D., Tong W., Yu D., Ning B. (2017) The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Biochem. Pharmacol., 145, 178-191. CrossRef Scholar google search
Anakk S., Huang W., Staudinger J.L., Tan K., Cole T.J., Moore D.D., Strobel H.W. (2007) Gender dictates the nuclear receptor-mediated regulation of CYP3A44. Drug Metab. Dispos., 35(1), 36-42. CrossRef Scholar google search
Wang Q., Tang Q., Zhao L., Zhang Q., Wu Y., Hu H., Liu L., Liu X., Zhu Y., Guo A., Yang X. (2020) Time serial transcriptome reveals CYP2C29 as a key gene in hepatocellular carcinoma development. Cancer Biol. Med., 17, 401-417. CrossRef Scholar google search
Chen M., Chen M., Lu D., Wang Y., Zhang L., Wang Z., Wu B. (2021) Period 2 regulates CYP2B10 expression and activity in mouse liver. Front. Pharmacol., 12, 764124. CrossRef Scholar google search
MacNaul K.L., Moller D.E. (2003) Peroxisome Proliferator- Activated Receptors. In: Encyclopedia of Hormones (Henry H.L., Norman A.W., eds), Academic Press, pp. 178-186. CrossRef Scholar google search
Burris-Hiday S.D., Scott E.E. (2021) Steroidogenic cytochrome P450 17A1 structure and function. Mol. Cell. Endocrinol., 528, 111261. CrossRef Scholar google search
Milona A., Massafra V., Vos H., Naik J., Artigas N., Paterson H.A.B., Bijsmans I.T.G.W., Willemsen E.C.L., Ramos Pittol J.M., Miguel-Aliaga I., Bosma P., Burgering B.M.T., Williamson C., Vernia S., Dhillo W.S., van Mil S.W.C., Owen B.M. (2019) Steroidogenic control of liver metabolism through a nuclear receptor-network. Molecular Metabolism, 30, 221-229. CrossRef Scholar google search
Ketlinsky S.A., Simbirtsev A.S. (2008) Cytokines. - St. Petersburg: Foliant Publishing LLC, pp. 70-79, 104-120, 144-151, 235-243, 326-333. Scholar google search
Cogswell J.P., Godlevski M.M., Wisely G.B., Clay W.C., Leesnitzer L.M., Ways J.P., Gray J.G. (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J. Immunol., 153(2), 712-723. CrossRef Scholar google search
Rutz S., Ouyang W. (2016) Regulation of Interleukin-10 Expression. In: Regulation of Cytokine Gene Expression in Immunity and Diseases (Ma X., ed.). Advances in Experimental Medicine and Biology, 941, 43-47. CrossRef Scholar google search
Vedi M., Smith J.R., Hayman G.T., Tutaj M., Brodie K.C., de Pons J.L., Demos W.M., Gibson A.C., Kaldunski M.L., Lamers L., Laulederkind S.J.F., Thota J., Thorat K., Tutaj M.A., Wang S.-J., Zacher S., Dwinell M.R., Kwitek A.E. (2023) 2022 updates to the rat genome database: A findable, accessible, interoperable, and reusable (FAIR) resource. Genetics, 224(1), iyad042. CrossRef Scholar google search
Devi A., Devaraj H. (2006) Induction and expression of GST-Pi foci in the liver of cyclophosphamideadministered rats. Toxicology, 217(2-3), 120-128. CrossRef Scholar google search
Oesch-Bartlomowicz B., Oesch F. (2007) 5.08 – Mechanisms of Toxification and Detoxification which Challenge Drug Candidates and Drugs. In: Comprehensive Medicinal Chemistry II (Taylor J.B., Triggle D.J., eds.), Elsevier, pp. 193-214. CrossRef Scholar google search
Spielberg S.P. (1996) N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism. J. Pharmacokinet. Biopharm., 24(5), 509-519. CrossRef Scholar google search
Udomsuk L., Jarukamjorn K. (2009) Factors influencing regulation of CYP2B expression. Thai. Pharm. Health Sci. J., 4(4), 524-531. Scholar google search
Qian Z., Chen L., Liu J., Jiang Y., Zhang Y. (2023) The emerging role of PPAR-alpha in breast cancer. Biomed. Pharmacother., 161, 114420. CrossRef Scholar google search
Mansour D.F., Saleh D.O., Mostafa R.E. (2017) Genistein ameliorates cyclophosphamide-induced hepatotoxicity by modulation of oxidative stress and inflammatory mediators. Open Access Maced. J. Med. Sci., 5(7), 836-843. CrossRef Scholar google search
El-Baz F., Salama A., Sami A., Rania E. (2022) Lutein isolated from Scenedesmus obliquus microalga boosts immunity against cyclophosphamide-induced brain injury in rats. Sci. Rep., 12(1), 22601. CrossRef Scholar google search
Essani N.A., Fisher M.A., Jaeschke H. (1997) Inhibition of NF-κB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock, 7(2), 90-96. CrossRef Scholar google search
Deol P., Yang J., Morisseau C., Hammock B.D., Sladek F.M. (2019) Dimethyl sulfoxide decreases levels of oxylipin diols in mouse liver. Front. Pharmacol., 10, 580. CrossRef Scholar google search
Tan W., Luo X., Li W., Zhong J., Cao J., Zhu S., Chen X., Zhou R., Shang C., Chen Y. (2018) TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma. eBioMedicine, 40, 446-456. CrossRef Scholar google search
Li H., Wang Y., Zhang M., Hu J., Li Z., Han B. (2019) The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma. Transl. Cancer Res., 8(2), 532-541. CrossRef Scholar google search
Zhu H., Liu C. (2003) Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J. Virol., 77(9), 5493-5498. CrossRef Scholar google search
